- Insider Monkey•6 days ago
Palantir Technologies Inc and Merck & Co., Inc. (NYSE:MRK) German parent Merck KGaA have entered into a deal that will see them work together on a cancer data analytics project. This comes at a time when the use of technology for improved drug discovery is being adopted across the pharmaceutical industry. However, each of the […]
- Zacks•7 days ago
Germany-based Merck KGaA announced that it has expanded the distribution alliance with Roche Holding AG (RHHBY).
- Bloomberg•12 days ago
Merck KGaA said it will use Palantir Technologies Inc. software to analyze the reams of pharmaceutical, life sciences and chemical data it collects to help develop and deliver products more rapidly.
MKGAF: Summary for MERCK KGAA DM 5 - Yahoo Finance
Merck Kommanditgesellschaft auf Aktien (MKGAF)
Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
|Day's range||107.70 - 108.67|
|52-week range||94.87 - 111.02|
Trade prices are not sourced from all markets
|PE ratio (TTM)||29.83|
|Dividend & yield||N/A (N/A)|
|1y target est||N/A|